These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
167 related items for PubMed ID: 24062481
1. Persistence of detectable immunoglobulin M antibodies up to 8 years after infection with West Nile virus. Murray KO, Garcia MN, Yan C, Gorchakov R. Am J Trop Med Hyg; 2013 Nov; 89(5):996-1000. PubMed ID: 24062481 [Abstract] [Full Text] [Related]
2. Persistence of West Nile virus-specific antibodies in viremic blood donors. Prince HE, Tobler LH, Yeh C, Gefter N, Custer B, Busch MP. Clin Vaccine Immunol; 2007 Sep; 14(9):1228-30. PubMed ID: 17652525 [Abstract] [Full Text] [Related]
3. Seropositivity of West Nile virus among acute febrile patients in Ilorin, Nigeria. Odebisi-Omokanye MB, Suleiman MM, Sulaiman MK, Atolagbe SA. Vopr Virusol; 2024 Sep 26; 69(4):320-328. PubMed ID: 39361926 [Abstract] [Full Text] [Related]
4. Persistence of West Nile virus immunoglobulin M antibodies, Greece. Papa A, Danis K, Athanasiadou A, Delianidou M, Panagiotopoulos T. J Med Virol; 2011 Oct 26; 83(10):1857-60. PubMed ID: 21837805 [Abstract] [Full Text] [Related]
5. Development and persistence of West Nile virus-specific immunoglobulin M (IgM), IgA, and IgG in viremic blood donors. Prince HE, Tobler LH, Lapé-Nixon M, Foster GA, Stramer SL, Busch MP. J Clin Microbiol; 2005 Sep 26; 43(9):4316-20. PubMed ID: 16145071 [Abstract] [Full Text] [Related]
6. Immunoglobulin G avidity in differentiation between early and late antibody responses to West Nile virus. Fox JL, Hazell SL, Tobler LH, Busch MP. Clin Vaccine Immunol; 2006 Jan 26; 13(1):33-6. PubMed ID: 16425997 [Abstract] [Full Text] [Related]
7. Performance of immunoglobulin G (IgG) and IgM enzyme-linked immunosorbent assays using a West Nile virus recombinant antigen (preM/E) for detection of West Nile virus- and other flavivirus-specific antibodies. Hogrefe WR, Moore R, Lape-Nixon M, Wagner M, Prince HE. J Clin Microbiol; 2004 Oct 26; 42(10):4641-8. PubMed ID: 15472323 [Abstract] [Full Text] [Related]
8. [Persistence of antibodies specific to West Nile virus in blood of reconvalescents of Volgograd region]. Karan' LS, Fedorova MV, Gridneva KA, Zabolotnaia GA, Smelianskiĭ VP, Tkachenko GA, Malenko GV, Koliasnikova NM, Rusakova NV, Shishkina LV. Zh Mikrobiol Epidemiol Immunobiol; 2014 Oct 26; (6):85-9. PubMed ID: 25816520 [Abstract] [Full Text] [Related]
9. West Nile virus infection and serologic response among persons previously vaccinated against yellow fever and Japanese encephalitis viruses. Johnson BW, Kosoy O, Martin DA, Noga AJ, Russell BJ, Johnson AA, Petersen LR. Vector Borne Zoonotic Dis; 2005 Oct 26; 5(2):137-45. PubMed ID: 16011430 [Abstract] [Full Text] [Related]
10. Seroprevalence of West Nile virus-specific antibodies in a cohort of blood donors in northeastern Italy. Pierro A, Gaibani P, Manisera C, Dirani G, Rossini G, Cavrini F, Ghinelli F, Ghinelli P, Finarelli AC, Mattivi A, Macini PL, Castellani G, Landini MP, Sambri V. Vector Borne Zoonotic Dis; 2011 Dec 26; 11(12):1605-7. PubMed ID: 21867418 [Abstract] [Full Text] [Related]
11. Diagnostic significance of immunoglobulin G avidity in symptomatic and asymptomatic West Nile virus infection. Vilibic-Cavlek T, Kristofic B, Savic V, Kolaric B, Barbic L, Tabain I, Peric L, Sabadi D, Miklausic B, Potocnik-Hunjadi T, Zember S, Stevanovic V, Listes E, Savini G. Rev Soc Bras Med Trop; 2018 Dec 26; 51(5):591-595. PubMed ID: 30304263 [Abstract] [Full Text] [Related]
12. Persistence of anti-West Nile virus-specific antibodies among asymptomatic blood donors in northeastern Italy. Pierro A, Gaibani P, Manisera C, Rossini G, Finarelli AC, Ghinelli F, Macini P, Landini MP, Sambri V. Vector Borne Zoonotic Dis; 2013 Dec 26; 13(12):892-3. PubMed ID: 23919606 [Abstract] [Full Text] [Related]
14. Use of immunoglobulin G avidity assays for differentiation of primary from previous infections with West Nile virus. Levett PN, Sonnenberg K, Sidaway F, Shead S, Niedrig M, Steinhagen K, Horsman GB, Drebot MA. J Clin Microbiol; 2005 Dec 26; 43(12):5873-5. PubMed ID: 16333069 [Abstract] [Full Text] [Related]
15. Human West Nile Virus Lineage 2 Infection: Epidemiological, Clinical, and Virological Findings. Pacenti M, Sinigaglia A, Franchin E, Pagni S, Lavezzo E, Montarsi F, Capelli G, Barzon L. Viruses; 2020 Apr 18; 12(4):. PubMed ID: 32325716 [Abstract] [Full Text] [Related]
16. Seroprevalence of West Nile Virus among Healthy Blood Donors from Different National Populations Residing in Qatar. Dargham SR, Al-Sadeq DW, Yassine HM, Ahmed M, Kunhipurayil H, Humphrey JM, Abu-Raddad LJ, Nasrallah GK. Int J Infect Dis; 2021 Feb 18; 103():502-506. PubMed ID: 33248245 [Abstract] [Full Text] [Related]
17. West Nile virus in Canadian blood donors. Cameron C, Reeves J, Antonishyn N, Tilley P, Alport T, Eurich B, Towns D, Lane D, Saldanha J. Transfusion; 2005 Apr 18; 45(4):487-91. PubMed ID: 15819667 [Abstract] [Full Text] [Related]
18. Equine seroprevalence of West Nile virus antibodies in the UK in 2019. Folly AJ, Waller ESL, McCracken F, McElhinney LM, Roberts H, Johnson N. Parasit Vectors; 2020 Nov 26; 13(1):596. PubMed ID: 33243297 [Abstract] [Full Text] [Related]
19. Evaluations of commercial West Nile virus immunoglobulin G (IgG) and IgM enzyme immunoassays show the value of continuous validation. Malan AK, Martins TB, Hill HR, Litwin CM. J Clin Microbiol; 2004 Feb 26; 42(2):727-33. PubMed ID: 14766844 [Abstract] [Full Text] [Related]
20. West Nile virus infection among health-fair participants, Wyoming 2003: assessment of symptoms and risk factors. Murphy TD, Grandpre J, Novick SL, Seys SA, Harris RW, Musgrave K. Vector Borne Zoonotic Dis; 2005 Feb 26; 5(3):246-51. PubMed ID: 16187893 [Abstract] [Full Text] [Related] Page: [Next] [New Search]